Indian Regulators Set Price Caps for More Pharmaceuticals
In mid-July 2014, Indias National Pharmaceutical Pricing Authority (NPPA) announced price controls for 50 diabetic and cardiac medicines. Drugs included in this round of price caps include heparin and atorvastatin. This move comes on the heels of substantial price reductions to more... Read More